May 5 - The U.S. Food and Drug Administration on Tuesday authorized the marketing of fruit-flavored e-cigarette pods from Los Angeles-based Glas Inc., the first time the agency has cleared non-tobacco-flavored vaping products for sale. The approved flavors listed by the agency include Classic Menthol, Fresh Menthol, Gold and Sapphire.
In announcing the authorization, the FDA said it conducted a detailed scientific review and concluded that Glas’s device access restriction technology, when combined with FDA-required marketing restrictions, "is expected to effectively mitigate the ability of youth to use the product." The company is described as a small vape maker that employs technology intended to gate access by age.
The decision comes amid a backdrop of growing political pressure on regulators. Earlier Tuesday, media reports said President Donald Trump rebuked FDA Commissioner Marty Makary over the pace of approvals for flavored vaping and nicotine products. The FDA had previously avoided authorizing flavored vapes and maintained that flavors with strong youth appeal - such as fruit or candy - require a substantial demonstration of net benefits to adult smokers.
Regulatory posture at the agency softened earlier this year, according to the agency statement, reflecting a recalibration of its strict approach to flavored e-cigarettes. That shift has been noted as occurring alongside intensified lobbying from the tobacco industry and other political pressures to allow more products onto the market.
With the Glas decision, the FDA has now authorized 45 e-cigarette products for sale in the United States. The agency emphasized that authorization was based on evidence related to access-restriction technology and accompanying marketing limits rather than on any change to the standard evidence burden for flavors that appeal to youth.
Context and takeaways
- The approval marks the first U.S. authorization of fruit-flavored vaping products, conditional on age-gating technology and marketing controls.
- The action follows reported political pressure on the FDA and increased lobbying from the tobacco sector.
- The FDA retains a high evidentiary bar for flavors that could be attractive to youth, even as it authorizes specific products with access controls.
The outcome represents a narrowly framed regulatory acceptance of a flavored product under specified safeguards rather than a broad policy change; the agency continues to require evidence that flavored products yield public health benefits to adult smokers that outweigh youth risks.